Company: ANIX
Filing Date: 2025-09-10
Form Type: S-3
Source: 0001493152-25-013010
Chunk: 33

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: S-3
Chunk 33
---
 that counsel will be named in the applicable prospectus supplement.

<div align='center'>EXPERTS</div>

The consolidated financial statements of Anixa Biosciences, Inc. and subsidiaries as of and for the years ended October 31, 2024 and 2023 have been incorporated by reference in the registration statement in reliance upon the report of Haskell & White LLP, independent registered public accounting firm, and upon the authority of said firm as experts in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

We file annual, quarter and periodic reports, proxy statements and other information with the Securities and Exchange Commission using the Commission’s EDGAR system. The Commission maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the Commission. The address of such site is http//www.sec.gov.

<div align='center'>INCORPORATION OF DOCUMENTS BY REFERENCE</div>

We are “incorporating by reference” in this prospectus certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. We have filed the following documents with the SEC and they are incorporated herein by reference as of their respective dates of filing.

| 1. 
 2. | Our Annual Report on Form 10-K for the year ended October 31,                                                                             
 2024, filed with the SEC on January 10, 2025;                                                                                             
 Our Quarterly Report on Form 10-Q for the quarter ended January 31, 2025, filed with the SEC on March 11, 2025;                           |
|:---|:------------------------------------------------------------------------------------------------------------------------------------------|
| 3. | Our Quarterly Report on Form 10-Q for the quarter ended April 30, 2025, filed with the SEC on May 28, 2025;                               |
| 4. | Our Quarterly Report on Form 10-Q for the quarter ended July 31, 2025, filed with the SEC on September                                    
 10, 202